Variant report
Variant | esv1820362 |
---|---|
Chromosome Location | chr8:6828226-6883059 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:51)
- CpG islands (count:427)
- Chromatin interactive region (count:2)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr8:6829807-6830004 | K562 | blood: | n/a | n/a |
2 | BACH1 | chr8:6829927-6829940 | H1-hESC | embryonic stem cell: | n/a | n/a |
3 | CEBPB | chr8:6882761-6882780 | H1-hESC | embryonic stem cell: | n/a | n/a |
4 | CEBPB | chr8:6882109-6882181 | A549 | lung: | n/a | n/a |
5 | CEBPB | chr8:6872820-6873018 | HepG2 | liver: | n/a | chr8:6872838-6872849 chr8:6872837-6872848 |
6 | CTCF | chr8:6841333-6841432 | GM10248 | blood: | n/a | n/a |
7 | CTCF | chr8:6870668-6870718 | Lung_OC | lung: | n/a | n/a |
8 | CTCF | chr8:6830796-6830848 | Lung_OC | lung: | n/a | n/a |
9 | CTCF | chr8:6850725-6850800 | Lung_OC | lung: | n/a | n/a |
10 | CTCF | chr8:6830206-6830256 | Kidney_OC | kidney: | n/a | n/a |
11 | CTCF | chr8:6829829-6829883 | LNCaP | prostate: | n/a | n/a |
12 | CTCF | chr8:6863352-6863389 | GM13977 | blood: | n/a | n/a |
13 | CTCF | chr8:6876641-6876732 | GM13976 | blood: | n/a | n/a |
14 | CTCF | chr8:6833327-6833368 | Kidney_OC | kidney: | n/a | n/a |
15 | CTCF | chr8:6832055-6832125 | GM13976 | blood: | n/a | n/a |
16 | CTCF | chr8:6829826-6829954 | LNCaP | prostate: | n/a | n/a |
17 | CTCF | chr8:6875862-6875906 | Kidney_OC | kidney: | n/a | n/a |
18 | CTCF | chr8:6829420-6829509 | LNCaP | prostate: | n/a | n/a |
19 | CTCF | chr8:6868755-6868819 | GM13976 | blood: | n/a | n/a |
20 | FOS | chr8:6829914-6829972 | MCF10A-Er-Src | breast: | n/a | n/a |
21 | GABPA | chr8:6878604-6878734 | Hela-S3 | cervix: | n/a | n/a |
22 | JUN | chr8:6829918-6830101 | K562 | blood: | n/a | n/a |
23 | JUN | chr8:6829481-6830053 | K562 | blood: | n/a | n/a |
24 | JUND | chr8:6829930-6830012 | HepG2 | liver: | n/a | n/a |
25 | JUND | chr8:6829760-6830100 | K562 | blood: | n/a | n/a |
26 | JUND | chr8:6829764-6829956 | H1-hESC | embryonic stem cell: | n/a | n/a |
27 | JUND | chr8:6829868-6829984 | H1-hESC | embryonic stem cell: | n/a | n/a |
28 | KAP1 | chr8:6829739-6830136 | U2OS | brain: | n/a | n/a |
29 | KAP1 | chr8:6829741-6830106 | HEK293 | kidney: | n/a | n/a |
30 | MAFF | chr8:6829846-6829893 | HepG2 | liver: | n/a | n/a |
31 | MAFK | chr8:6829930-6829935 | HepG2 | liver: | n/a | n/a |
32 | MAFK | chr8:6829763-6829959 | H1-hESC | embryonic stem cell: | n/a | chr8:6829896-6829907 chr8:6829896-6829907 chr8:6829891-6829906 |
33 | MAFK | chr8:6829943-6829957 | Hela-S3 | cervix: | n/a | n/a |
34 | MAFK | chr8:6829787-6829987 | HepG2 | liver: | n/a | chr8:6829896-6829907 chr8:6829896-6829907 chr8:6829891-6829906 |
35 | POLR2A | chr8:6845770-6845778 | MCF-7 | breast: | n/a | n/a |
36 | POLR2A | chr8:6882752-6882809 | GM12878 | blood: | n/a | n/a |
37 | POLR2A | chr8:6845727-6845752 | MCF-7 | breast: | n/a | n/a |
38 | POLR2A | chr8:6838321-6838399 | Gliobla | brain: | n/a | n/a |
39 | POLR2A | chr8:6857571-6857648 | Gliobla | brain: | n/a | n/a |
40 | SETDB1 | chr8:6829763-6830144 | U2OS | brain: | n/a | n/a |
41 | SPI1 | chr8:6861083-6861304 | GM12891 | blood: | n/a | chr8:6861225-6861238 |
42 | SPI1 | chr8:6837542-6837676 | K562 | blood: | n/a | chr8:6837626-6837639 |
43 | SPI1 | chr8:6847171-6847347 | K562 | blood: | n/a | n/a |
44 | SPI1 | chr8:6866274-6866450 | K562 | blood: | n/a | n/a |
45 | SPI1 | chr8:6841978-6842199 | GM12891 | blood: | n/a | chr8:6842120-6842133 |
46 | SPI1 | chr8:6875751-6875885 | K562 | blood: | n/a | chr8:6875835-6875848 |
47 | SPI1 | chr8:6856652-6856786 | K562 | blood: | n/a | chr8:6856736-6856749 |
48 | TEAD4 | chr8:6843178-6843665 | H1-hESC | embryonic stem cell: | n/a | n/a |
49 | TEAD4 | chr8:6862289-6862645 | H1-hESC | embryonic stem cell: | n/a | n/a |
50 | TEAD4 | chr8:6843230-6843570 | H1-hESC | embryonic stem cell: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:6837932-6837982 | A549 | lung: | n/a |
2 | chr8:6838024-6838074 | A549 | lung: | n/a |
3 | chr8:6838024-6838074 | GM12891 | blood: | n/a |
4 | chr8:6876781-6876831 | HCM | heart: | n/a |
5 | chr8:6837932-6837982 | HNPCEpiC | eye: | n/a |
6 | chr8:6876781-6876831 | HPAEpiC | pulmonary alveolar: | n/a |
7 | chr8:6873754-6873804 | SK-N-SH | brain: | n/a |
8 | chr8:6873754-6873804 | Jurkat | blood: | n/a |
9 | chr8:6876695-6876745 | K562 | blood: | n/a |
10 | chr8:6876781-6876831 | SK-N-MC | brain: | n/a |
11 | chr8:6875661-6875711 | T-47D | breast: | n/a |
12 | chr8:6838024-6838074 | LNCaP | prostate: | n/a |
13 | chr8:6875661-6875711 | ECC-1 | luminal epithelium: | n/a |
14 | chr8:6876155-6876205 | HNPCEpiC | eye: | n/a |
15 | chr8:6875661-6875711 | HCT-116 | colon: | n/a |
16 | chr8:6837932-6837982 | ProgFib | skin: | n/a |
17 | chr8:6876695-6876745 | HRPEpiC | eye: | n/a |
18 | chr8:6876781-6876831 | Jurkat | blood: | n/a |
19 | chr8:6876781-6876831 | SK-N-SH | brain: | n/a |
20 | chr8:6837932-6837982 | AG09309 | skin: | n/a |
21 | chr8:6876781-6876831 | AG10803 | skin: | n/a |
22 | chr8:6876781-6876831 | HEEpiC | esophagus: | n/a |
23 | chr8:6873754-6873804 | NB4 | blood: | n/a |
24 | chr8:6873754-6873804 | HRPEpiC | eye: | n/a |
25 | chr8:6838024-6838074 | HCF | heart: | n/a |
26 | chr8:6875661-6875711 | GM06990 | blood: | n/a |
27 | chr8:6838024-6838074 | AG04449 | skin: | fetal |
28 | chr8:6837932-6837982 | HCT-116 | colon: | n/a |
29 | chr8:6876695-6876745 | NT2-D1 | testis: | n/a |
30 | chr8:6838024-6838074 | H1-hESC | embryonic stem cell: | embryo |
31 | chr8:6838024-6838074 | AG09309 | skin: | n/a |
32 | chr8:6873754-6873804 | Caco-2 | colon: | n/a |
33 | chr8:6876155-6876205 | A549 | lung: | n/a |
34 | chr8:6875661-6875711 | AoSMC | blood vessel: | n/a |
35 | chr8:6876155-6876205 | T-47D | breast: | n/a |
36 | chr8:6876155-6876205 | ProgFib | skin: | n/a |
37 | chr8:6873754-6873804 | IMR90 | lung: | fetal |
38 | chr8:6876155-6876205 | SK-N-MC | brain: | n/a |
39 | chr8:6837932-6837982 | Jurkat | blood: | n/a |
40 | chr8:6875661-6875711 | K562 | blood: | n/a |
41 | chr8:6876781-6876831 | HRCEpiC | kidney: | n/a |
42 | chr8:6837932-6837982 | HCM | heart: | n/a |
43 | chr8:6876695-6876745 | HEK293 | kidney: | embryo |
44 | chr8:6837932-6837982 | GM12891 | blood: | n/a |
45 | chr8:6838024-6838074 | Jurkat | blood: | n/a |
46 | chr8:6876695-6876745 | HCPEpiC | choroid plexus: | n/a |
47 | chr8:6876695-6876745 | HepG2 | liver: | n/a |
48 | chr8:6876155-6876205 | HCF | heart: | n/a |
49 | chr8:6875661-6875711 | NHBE | bronchial: | n/a |
50 | chr8:6875661-6875711 | MCF10A-Er-Src | breast: | n/a |
(count:2 , 50 per page) page:
1
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-DEFA1B-1 | chr8:6845622-6845808 | NONHSAT124804 |
2 | lnc-DEFA1B-1 | chr8:6847181-6847243 | NONHSAT124804 |
3 | lnc-DEFA1B-1 | chr8:6844700-6844945 | NONHSAT124804 |
No data |
No data |
Variant related genes | Relation type |
---|---|
DEFA3 | TF binding region |
DEFT1P | TF binding region |
DEFA1B | TF binding region |
DEFT1P2 | TF binding region |
DEFA10P | TF binding region |
DEFA1 | TF binding region |
DEFA3 | CpG island |
DEFT1P | CpG island |
DEFA1B | CpG island |
DEFT1P2 | CpG island |
DEFA10P | CpG island |
DEFA1 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2978916 | chr8:6828241-6828242 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs188924352 | chr8:6828268-6828269 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs200934795 | chr8:6828280-6828281 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563880345 | chr8:6828306-6828307 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116962163 | chr8:6828318-6828319 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs549648407 | chr8:6828367-6828368 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566271946 | chr8:6828382-6828383 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs368934385 | chr8:6828388-6828389 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs371296356 | chr8:6828421-6828422 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs2615765 | chr8:6828431-6828432 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs10088393 | chr8:6828435-6828436 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs367879456 | chr8:6828440-6828441 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs371660150 | chr8:6828463-6828464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115374166 | chr8:6828520-6828521 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs555901617 | chr8:6828529-6828530 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs74759406 | chr8:6828555-6828556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs147460547 | chr8:6828582-6828583 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs535930006 | chr8:6828584-6828585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs148480004 | chr8:6828606-6828607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs2615766 | chr8:6828609-6828610 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs375660522 | chr8:6828610-6828611 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577769986 | chr8:6828621-6828622 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs543532483 | chr8:6828622-6828623 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs563420248 | chr8:6828631-6828632 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs141801105 | chr8:6828634-6828635 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs549347211 | chr8:6828637-6828638 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs2615767 | chr8:6828647-6828648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs181975360 | chr8:6828659-6828660 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs528804920 | chr8:6828660-6828661 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2927342 | chr8:6828667-6828668 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs186354788 | chr8:6828669-6828670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs116044722 | chr8:6828670-6828671 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537089760 | chr8:6828679-6828680 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs116350966 | chr8:6828684-6828685 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs369531559 | chr8:6828713-6828714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs535600868 | chr8:6828717-6828718 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs115348329 | chr8:6828730-6828731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs571451114 | chr8:6828757-6828758 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551825003 | chr8:6828761-6828762 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs71525780 | chr8:6828766-6828767 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs534923508 | chr8:6828770-6828771 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs12682063 | chr8:6828781-6828782 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs150557384 | chr8:6828785-6828786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs12682076 | chr8:6828791-6828792 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs12675296 | chr8:6828795-6828796 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
46 | rs573670894 | chr8:6828810-6828811 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12675298 | chr8:6828813-6828814 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs559696318 | chr8:6828819-6828820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73661317 | chr8:6828832-6828833 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs545289517 | chr8:6828837-6828838 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Crohn''s disease | 19220326 | CNVD |
Psoriasis | 19220326 | CNVD |
Prostate cancer | 21965145 | CNVD |
Prostate cancer | 18515986 | CNVD |
Chronic obstructive pulmonary disease | 20378733 | CNVD |
Autism | 18414403 | CNVD |
Cancer | 21183584 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Breast cancer | 17603634 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Cervical cancer | 17311676 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Schizophrenia | 20877625 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 17001317 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Heart disease | 21282601 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Breast cancer | 17393978 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Breast cancer | 21785460 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21509527 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Epilepsy | 22083797 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Congenital diaphragmatic hernia | 21064195 | CNVD |
Autism | 22495311 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16608533 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung squamous cell carcinoma | 22363434 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Gastric cancer | 18160780 | CNVD |
Breast cancer | 21990379 | CNVD |
Psoriasis | 20403174 | CNVD |
Psoriasis | 20663923 | CNVD |
Crohn''s disease | 16909382 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Crohn''s disease | 20877625 | CNVD |
Inflammatory disorder | 20877625 | CNVD |
Cardiac defect | 21933911 | CNVD |
Psoriasis | 18059266 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Psoriasis | 20877625 | CNVD |
Mental retardation | 17847001 | CNVD |
Prostate cancer | 17217626 | CNVD |
Schizophrenia | 21399695 | CNVD |
Colorectal cancer | 21128281 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Psoriasis | 18848619 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Colorectal cancer | 17229543 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Bladder cancer | 21909424 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Breast cancer | 17142309 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Autism | 21865298 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Behcet''s disease | 22219625 | CNVD |
Crohn''s disease | 21701837 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:6794600-6829200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr8:6822800-6830000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr8:6824800-6829200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:6828200-6828600 | Enhancers | H1 Cell Line | embryonic stem cell |
5 | chr8:6828200-6828600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr8:6828400-6828600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr8:6828600-6829600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr8:6829200-6829400 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |
9 | chr8:6829200-6829400 | Enhancers | Right Ventricle | heart |
10 | chr8:6829200-6830200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr8:6829600-6830000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
12 | chr8:6829600-6830000 | Enhancers | Fetal Brain Male | brain |
13 | chr8:6829600-6830200 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
14 | chr8:6829800-6830000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
15 | chr8:6830000-6833000 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
16 | chr8:6831000-6831200 | Enhancers | Primary mononuclear cells fromperipheralblood | Blood |
17 | chr8:6833000-6833600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
18 | chr8:6833600-6837800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
19 | chr8:6837800-6838200 | Enhancers | Primary neutrophils fromperipheralblood | blood |
20 | chr8:6838200-6840600 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
21 | chr8:6840600-6841800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
22 | chr8:6856800-6857400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
23 | chr8:6863200-6866800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
24 | chr8:6867000-6871800 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
25 | chr8:6871800-6873000 | Enhancers | Primary neutrophils fromperipheralblood | blood |
26 | chr8:6872400-6872600 | Enhancers | Primary hematopoietic stem cells | blood |
27 | chr8:6873000-6873400 | Weak transcription | Primary neutrophils fromperipheralblood | blood |
28 | chr8:6873400-6884600 | Enhancers | Primary neutrophils fromperipheralblood | blood |
29 | chr8:6879800-6881200 | Enhancers | Dnd41 | blood |
30 | chr8:6881200-6881400 | Bivalent Enhancer | ES-WA7 Cell Line | embryonic stem cell |
31 | chr8:6882000-6882400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
32 | chr8:6882200-6882400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |